Top Story

Antibiotic use and cancer risk: Repeat exposure poses harm

October 9, 2015

For years, data have suggested that previous exposure to antibiotics may be associated with an increased risk for diabetes, as well as an increased risk for obesity among certain populations.

Research now suggests that years of repeat exposure to various antibiotics is associated with an increased risk for specific cancer types.

CMS, ONC issue new rules to make EHR better accessed, more useful

October 9, 2015
HHS has issued new rules to the Electronic Heath Record Incentive Program and the Health IT Certification Program that will make EHR information more available to…
FDA News

FDA grants priority review to rociletinib for advanced NSCLC

October 9, 2015
The FDA granted priority review to a new drug application for rociletinib.Rociletinib (Clovis Oncology) — a novel, oral, targeted covalent mutant-selective…
Leisha Ann Emens In the Journals

PANVAC plus docetaxel may have clinical benefit for metastatic breast cancer

October 9, 2015
The addition of a poxviral-based cancer vaccine, or PANVAC, to docetaxel may confer a clinical benefit for patients with metastatic breast cancer, according to the…
In the Journals

Minimally invasive surgical approaches inferior to open resection for rectal cancer

October 9, 2015
The use of minimally invasive laparoscopic resection did not improve outcomes compared with open resection for patients with rectal cancer, according to the results of…
More News Headlines »
Hematology Oncology Case Consults

The Patient with Invasive Breast Cancer

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with invasive breast cancer.
More »
VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

September 30, 2015
The development of new treatments for patients with advanced melanoma in the past decade has been…
More »
Diabetic Eye Disease Consults: Volume 1, Number 1

Updates in Melanoma 2015: Entering a New Therapeutic Era

This activity is supported by an educational grant from Merck & Co., Inc.

The incidence of melanoma, an aggressive disease that accounts for approximately 75% of skin-cancer-related deaths, is…
More »